<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Medical Sciences Division</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1697E489-7385-4E68-84DC-C4D5761AC3E1"><gtr:id>1697E489-7385-4E68-84DC-C4D5761AC3E1</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Kennard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801678"><gtr:id>39B5A22F-808D-4FAA-83FA-345452196078</gtr:id><gtr:title>DPFS resource request (University of Oxford) development pathway director</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801678</gtr:grantReference><gtr:abstractText>This new activity will accelerate the uptake of existing scientific discoveries made by biomedical researchers at the University of Oxford. We will create a fast-track process for bringing these discoveries into hospitals to improve medical care.</gtr:abstractText><gtr:technicalSummary>To accelerate the translation of our biomedical research outputs, we request support to recruit an experienced director from industry to establish and lead an Oxford development pathway, capable of managing a portfolio of eight to ten parallel development projects.</gtr:technicalSummary><gtr:fund><gtr:end>2014-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>166884</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UCB neuroscience projects in the areas of Parkinson's disease, Cognition and Epilepsy</gtr:description><gtr:id>36BDF5EE-C9F6-411E-A3A5-4E98EF89C2CF</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>The University of Oxford and UCB have (21st March 2012) signed a partnership worth &amp;pound;3.6M to work together on cutting-edge pharmaceutical research projects. The new collaboration will see scientists from industry and academia working together to develop innovative medicines to treat serious diseases in the areas of immunology and neurology.
UCB have already signed up neuroscience projects in the areas of Parkinson's disease, Cognition and Epilepsy.</gtr:partnerContribution><gtr:piContribution>Research facilitation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Translational Neuroscience Research Portfolio Manager/ Research Coordinator</gtr:description><gtr:id>AAF54516-2C8A-49B0-8CBD-2A635ECCEBE3</gtr:id><gtr:impact>Tripartite Oxford McGill ZNZ Neuroscience collaboration has already attracted approx &amp;pound;500K of funding.</gtr:impact><gtr:partnerContribution>The Oxford McGill neuroscience collaboration and the new Tripartite Oxford McGill ZNZ Partnership in the Neurosciences develop collaborative programmes of research between the partner institutes</gtr:partnerContribution><gtr:piContribution>Translational Neuroscience Research Portfolio Manager/ 
Research Coordinator wrote Translational Neuroscience document for industry. Have sent to J&amp;amp;J, Grunenthal, BMS, Merck. Also fostered relations with Eli Lilly, UCB and J&amp;amp;J. Hosted visits from Roche, Abbvie. Visited Eli lilly and Vertex to showcase Oxford neuroscience
Established collaboration with Hotchkiss Brain Institute, Calgary including successful summer exchange studentship scheme, now in its third year, and two joint symposia 2014 and 2015.
Effectively co-ordinated McGill collaboration. Co-ordinated establishment of Tripartite Oxford McGill ZNZ Neuroscience collaboration. This has already attracted approx &amp;pound;500K of funding and has successfully completed its first funding round.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Translational Neuroscience Research Portfolio Manager/  Research Coordinator</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CDB39C5E-287D-4A7D-91BB-64749F18D395</gtr:id><gtr:impact>Translational Neuroscience Research Portfolio Manager/Research Coordinator organised public engagement activities including Revealing the Brain exhibition March 2013 and Sleep and the Brain March 2013. Sleep and the Brain attracted 2,255 visitors. Brain Awareness Week 2014
Organised other public engagement activities including 'Reaction Time Race' accepted for Festival of Neuroscience street fair April 2013, London International Youth Science Fair 2012 and 2013, Generating Genius April 2013 and 2014, BRC open days 2012, 2013 and 2014. Organised 'Translational aspects of Neuroscience Research' March 2013, 'Optogenetics - Controlling the Brain with Light' joint BNA Oxford venture April 2014.
Implemented Bi-monthly e-Newsletter that has attracted positive feedback from both University and internationally. Implemented an updated new website. Also created twitter stream to promote Oxford publications etc. To date we have tweeted 855 tweets and attracted 4,447 followers including: MRC, BBSRC, NIHR, KCL, Parkinson's UK, Ataxia UK, Physiol Soc, and NC3Rs


We have received very positive feedback from the Museum of the History of Science and Generating Genius. These organisations have asked to establish and ongoing relationship in which we will become a regular part of their engagement calendars</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">G0801678</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>